Procyon Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Procyon with three other
pharmaceutical manufacturers in North America:
MEI Pharma Incorporation
sales of $4.92 million
of which 100%
was Development of Pharmaceutical compounds),
Polydex Pharmaceuticals Limited
based in Canada
(6.46 million Canadian Dollars [US$4.90 million]
Procyon reported sales of $4.19 million
June of 2019.
increase of 4.3%
versus 2018, when the company's sales were $4.02 million.
This was the fourth straight year of sales growth at Procyon.